Drug-resistant infections surge 70% in the U.S.
Drug-resistant infections in the U.S. rose by 70% between 2019 and 2023, driven by strains with the NDM gene, CDC data reveals.
Why it matters
- These infections resist nearly all antibiotics, including last-resort carbapenems, leaving limited treatment options.
By the numbers
- 4,300+ cases in 2023, with NDM gene-linked cases up 460%. Carbapenem-resistant infections rose from 2 to 3 per 100,000 people.
The big picture
- Antibiotic misuse and pandemic-related antibiotic overuse are likely contributors. The CDC data excludes major states, suggesting higher actual numbers.
What they're saying
- Experts warn of a grave danger as routine infections become harder to treat. Comments highlight concerns over antibiotic misuse and the need for new research to combat resistance.
Caveats
- The data may undercount actual cases due to limited testing capabilities and excluded states.
What’s next
- Addressing antibiotic misuse and investing in new treatments are critical to curb resistance.